Oncternal Therapeutics

Oncternal Therapeutics, Tokalas merge

Wednesday, June 8, 2016

Oncternal Therapeutics and Tokalas have completed a merger to create a new world-class clinical-stage oncology company with two promising, first-in-class pipeline products. The transaction was approved by both companies’ shareholders, and results in the combination of all assets, R&D programs and operations under the name Oncternal Therapeutics.

[Read More]